Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chengda Sudar lyophilized human rabies vaccine (Vero cell) post‑marketing 2-1-1 vs 5-dose immunogenicity and safety study
CTR20140353Phase 4Completed
- Sponsor
- Liaoning Chengda Biotechnology Co., Ltd.
- Start
- May 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of rabies vaccine (vero cell) in rabies, sponsored by Liaoning Chengda Biotechnology Co., Ltd.. Started May 2014; status: completed.
02
Drugs
rabies vaccine (vero cell)
03
Conditions
rabies
Beyond the preview
Go deeper on CTR20140353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140353.